Gleostine (Lomustine) Capsules
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
January 2016
BOXED WARNING
* Boxed warning updated to read:
WARNING: DELAYED MYELOSUPPRESSION and RISK OF OVERDOSAGE
...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology | Warnings